Yannick Allanore

Active 2003–2026

240
Papers
31,180
Citations
97
h-index
228
i10-index

Citations

Citations per year for Yannick Allanore1978: 1 citations1982: 1 citations1998: 5 citations2000: 2 citations2004: 3 citations2005: 7 citations2006: 20 citations2007: 32 citations2008: 51 citations2009: 74 citations2010: 121 citations2011: 114 citations2012: 141 citations2013: 132 citations2014: 167 citations2015: 138 citations2016: 161 citations2017: 207 citations2018: 175 citations2019: 1,094 citations2020: 1,270 citations2021: 1,386 citations2022: 1,274 citations2023: 808 citations2024: 1,306 citations2025: 653 citations2026: 8 citations1979–1981: no citations, so these years are not shown1983–1997: no citations, so these years are not shown1999: no citations, so this year is not shown2001–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,663 citing papers, 16.7% of this breakdownItaly: 918 citing papers, 9.2% of this breakdownUnited Kingdom: 816 citing papers, 8.2% of this breakdownFrance: 751 citing papers, 7.6% of this breakdownChina: 610 citing papers, 6.1% of this breakdownGermany: 608 citing papers, 6.1% of this breakdownNetherlands: 369 citing papers, 3.7% of this breakdownSwitzerland: 360 citing papers, 3.6% of this breakdownJapan: 338 citing papers, 3.4% of this breakdownCanada: 332 citing papers, 3.4% of this breakdownSpain: 322 citing papers, 3.3% of this breakdownBelgium: 219 citing papers, 2.2% of this breakdown
0%16.7%Other 26.5%

Fields

  • Medicine85.5%
  • Biochemistry, Genetics and Molecular Biology7.3%
  • Immunology and Microbiology5.4%
  • Neuroscience0.6%
  • Engineering0.3%
  • Health Professions0.2%
  • Other0.7%

Topics

  • Systemic Sclerosis and Related Diseases16.4%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis9.1%
  • Inflammatory Myopathies and Dermatomyositis6.1%
  • Rheumatoid Arthritis Research and Therapies3.7%
  • Pulmonary Hypertension Research and Treatments3.6%
  • Systemic Lupus Erythematosus Research2.8%
  • Other58.3%

Coauthors

All papers

Open in search
  1. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 cited by 3,406

  2. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 cited by 652

  3. Mapping and predicting mortality from systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore - Annals of the Rheumatic Diseases 2017 cited by 684

  4. Systemic sclerosis

    Authors: , , , , , , - Nature Reviews Disease Primers 2015 cited by 862

  5. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 cited by 502

  6. Update of EULAR recommendations for the treatment of systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana and 35 more - Annals of the Rheumatic Diseases 2016 cited by 1,116

  7. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 669

  8. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 354

  9. Methotrexate and rheumatoid arthritis associated interstitial lung disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Christophe Boissier, Lidwine Wémeau-Stervinou, René‐Marc Flipo, S. Marchand‐Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie‐Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy J. Doyle, Jay H. Ryu, Iván O. Rosas, V. Michael Holers, Cathérine Boileau, Marie‐Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2020 cited by 236

  10. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

    Authors: , , , , , , , , , , , , , , , , , - Journal of Scleroderma and Related Disorders 2017 cited by 521

  11. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Luís Callejas-Rubio, José Antonio Vargas‐Hitos, Rosa García-Portales, M T Camps, Antonio Fernández‐Nebro, Marı́a-Francisca González-Escribano, Francisco José García Hernández, María Jesús Castillo, M. Á. Aguirre, Inmaculada Gómez-Gracia, Benjamín Fernández‐Gutiérrez, Luis Rodríguez‐Rodríguez, Paloma García de la Peña, Esther Vicente, José Luís Andreu, M. Fernández Castro, Francisco Javier López-Longo, Leticia Quintanilla Martinez, Fonollosa, Alberto Guillén, Gerard Espinosa, Carlos Tolosa, A. Pros, Mónica Rodríguez‐Carballeira, Javier Narváez, Manuel Rubio‐Rivas, Ortiz-Santamaría, Ana Belén Madroñero, Miguel Á. González‐Gay, Bianca J. Diaz, Luis Trapiella, André M. M. Sousa, M. V. Egurbide, P. Fanlo-Mateo, Luís Sáez-Comet, Fidel Díez Díaz, Hernández, E. Beltrán, José Andrés Román-Ivorra, Elena Grau, Juan José Alegre Sancho, M. Freire, Francisco J. Blanco, N. Oreiro, Torsten Witte, Alexander Kreuter, G. Riemekasten, Paolo Airó, C. Magro, Alexandre E. Voskuyl, M. C. Vonk, Roger Hesselstrand, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Australian Scleroderma Interest Group (ASIG), Jane Zochling, J. Sahhar, Janet Roddy, Peter Nash, Kathleen Tymms, Maureen Rischmueller, Sue Lester, Timothy J. Vyse, Ariane L. Herrick, Jane Worthington, Christopher P. Denton, Yannick Allanore, Matthew A. Brown, Timothy R. D. J. Radstake and 4 more - Nature Communications 2019 cited by 188

  12. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 cited by 364

  13. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 212

  14. Trained immunity modulates inflammation-induced fibrosis

    Authors: , , , , , , , , , - Nature Communications 2019 cited by 153

  15. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2017 cited by 263

  16. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature

    Authors: , , , , , , , , , , , , - Arthritis Research & Therapy 2019 cited by 217

  17. Targeting synovial neoangiogenesis in rheumatoid arthritis

    Authors: , , - Autoimmunity Reviews 2017 cited by 117

  18. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriela Riemekasten, Simona Rednic, Edoardo Rosato, Marta Saracco, A Scheja, Vanessa Smith, Carina Mihai, Gabriela Szucs, Matija Tomšič, Gabriele Valentini, Ulrich A. Walker, R Westhovens, Şule Yavuz, Thierry Zénone - Annals of the Rheumatic Diseases 2014 cited by 428

  19. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Krieg, R Marcolongo, Ilaria Galetti, Elisabetta Zanatta, Francesco Tona, Petar Seferović, Marco Matucci‐Cerinic - Journal of Scleroderma and Related Disorders 2021 cited by 75

  20. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    Authors: , , , , , , , , , , , , , , , , , - PLoS ONE 2016 cited by 277

  21. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Cottin, Marie‐Christophe Boissier, B. Wallaert, Thierry Schaeverbeke, F. Moal, Aline Frazier, Christelle Ménard, Martin Soubrier, Nathalie Saidenberg-Kermanac’h, Dominique Valeyre, Serge Amselem, Cathérine Boileau, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2017 cited by 233

  22. Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

    Authors: , , , , , , - Current Opinion in Rheumatology 2022 cited by 57

  23. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Authors: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 438

  24. EULAR recommendations for the treatment of systemic sclerosis: 2023 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2024 cited by 215